electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in BelgiumGlobeNewsWire • 09/29/25
electroCore's Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire's 2025 Sleep AwardsGlobeNewsWire • 09/22/25
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the BoardGlobeNewsWire • 09/05/25
electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress ReliefGlobeNewsWire • 09/04/25
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of TruvagaGlobeNewsWire • 08/12/25
electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025GlobeNewsWire • 07/23/25
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/07/25
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic TechnologiesGlobeNewsWire • 05/02/25
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025GlobeNewsWire • 04/30/25
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain InjuriesGlobeNewsWire • 04/17/25
electroCore Named One of The Americas' Fastest Growing Companies by the Financial TimesGlobeNewsWire • 04/03/25